Is it time to retire the best-before date?
The inventors of a suite of tests that enable food packages to signal if their contents are contaminated are working to bring producers and regulators together to get… read more.
The inventors of a suite of tests that enable food packages to signal if their contents are contaminated are working to bring producers and regulators together to get… read more.
Compared with people without opioid use disorder, those with opioid use disorder were less likely to receive palliative care in clinics and in their homes, and were dying… read more.
AbbVie announced positive topline results from LEVEL UP, an open-label, efficacy assessor-blinded head-to-head Phase IIIb/IV study that evaluated the efficacy and safety of upadacitinib (Rinvoq, 15 mg once… read more.
The way religious beliefs and medical treatments intersect can really affect how people use medications and stick to their treatment plans. Lately, there’s been talk about “Halal pharmaceuticals,”… read more.
On 25 April 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for… read more.
The number of health care professionals able to write a prescription for a key medication to treat addiction quadrupled at community health clinics from 2016 to 2021, according… read more.
An analysis of 15 name-brand drugs and their “skinny label” generic counterparts found that competition from these counterparts saved Medicare Part D nearly $15 billion from 2015 to… read more.
Frailty is a well-established predictor of complications and death after surgery. However, patients over 65 who undergo a high-risk operation in the emergency room are at significantly increased… read more.
Deborah Evans is a pharmacist and independent prescriber who specialises in women’s reproductive and sexual health, including the menopause. She owns and runs Remedi Health, an independent pharmacy… read more.
Novartis announced that the FDA approved Lutathera (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide) for the treatment of pediatric patients 12 years and older with… read more.
Researchers at Baylor College of Medicine in collaboration with the University of Arizona led a study that can help surgeons obtain biofeedback of their posture during long surgical… read more.
Atrial fibrillation, or AFib, is the most common type of irregular heartbeat, estimated to affect about 12.1 million U.S. adults by 2030.[1] The abnormal firing of electrical impulses causes… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.